RNA Amplification Kit Reducing Bias and Artifacts

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Microarray technology for gene expression analysis faces challenges with RNA amplification techniques that introduce amplification bias and produce non-specific artifacts, particularly when amplifying small RNA samples using the Eberwine method.

Innovation Solution

A method and kit for synthesizing antisense RNA (asRNA) molecules directly from sense RNA (sRNA) molecules by converting a partial RNA polymerase recognition sequence at the 3' ends into a complete RNA polymerase recognition sequence and forming a double-stranded RNA polymerase promoter, followed by RNA transcription using an RNA polymerase that recognizes this promoter.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If the Eberwine method is used for RNA amplification, then amplification of small RNA samples is achieved, but non-specific artifacts are produced

Engineering Contradiction:
Improveamplification of small RNA samplesVSAvoidnon-specific artifacts
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent segments the amplification process into distinct phases: first strand cDNA synthesis using a compound oligonucleotide with T7 promoter, second strand cDNA synthesis, and in vitro transcription. This segmentation allows control over artifact formation at each stage while maintaining amplification efficiency.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses cDNA as an intermediary molecule between the original RNA and the final amplified RNA product. The compound oligonucleotide acts as a mediator that incorporates the T7 promoter during first strand synthesis, enabling subsequent in vitro transcription without directly amplifying the original RNA with intact promoters that cause artifacts.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If compound oligonucleotide with intact T7 promoter is used, then RNA amplification is achieved, but amplification bias is introduced

Engineering Contradiction:
ImproveRNA amplificationVSAvoidamplification bias
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent applies local quality by placing the T7 promoter only at the 5' end of the first strand cDNA through the compound oligonucleotide, rather than having intact promoters distributed throughout the RNA population. This localized promoter placement ensures uniform transcription initiation and reduces amplification bias while maintaining high productivity.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach reduces non-specific artifacts and provides increased amplification of RNA molecules, particularly useful for small RNA samples, while maintaining the orientation and representation of the original RNA sequences, suitable for gene expression studies.

Implementation Method 1

Subsequent RNA transcription using an RNA polymerase that recognizes the double stranded RNA polymerase promoter results in the production of amplified asRNA molecules

Methodology Applied
Scientific EffectTranscription:

Implementation Method 2

annealing to the 3' end of the sRNA molecule a primer having a 5' end and a 3' end, said primer comprising a second nucleotide sequence corresponding to at the 5' end of the non-template strand of said RNA polymerase recognition sequence sufficient in length to anneal to said first nucleotide sequence

Methodology Applied
Scientific EffectHybridization:

Implementation Method 3

The sRNA molecules can be reverse transcribed into cDNA molecules

Methodology Applied
Scientific EffectReverse transcription:

Data Source

PatentUS8653251B2Methods and kits for nucleic acid amplification
Publication Date: 2014.02.18 GENISPHERE INC
  • US8653251B2 patent drawing
  • US8653251B2 patent drawing
  • US8653251B2 patent drawing

AI summary

Compositions and methods are provided for amplifying nucleic acid molecules. The nucleic acid molecules can be used in various research and diagnostic applications, such as gene expression studies involving nucleic acid microarrays.